PTC Therapeutics' Kebilidi gains FDA accelerated approval as the first brain-administered gene therapy in the U.S. for AADC ...

production and commercialization of recombinant therapeutic proteins produced by its proprietary ProCellEx ® plant cell-based protein expression system, today reported financial results for the ...

The Company currently has 12 listed patents for IGALMI in the FDA’s Approved Drug Products with Therapeutic Equivalence Evaluations ... sales activity reflects rising utilization. Cost of Goods Sold: ...

Supplements promising similar results to Ozempic have taken over social media, but the TGA and health experts have concerns.

Several ASX health stocks attended the 7th China International Import Expo, showcasing China's relationships with its trading ...

Reported Total DANYELZA net product revenues of $18.5 million for the third quarter of 2024 <li /> Entered into exclusive license and d ...

Q3 2024 Earnings Conference Call November 7, 2024 4:30 PM ETCompany ParticipantsLarry Heaton – Chief Executive OfficerMike ...

To regain compliance, Biomerica’s common stock must close at or above a $1.00 per share bid price for at least ten consecutive business days prior to May 5, 2025. The Company is actively pursuing ...

A person in South Australia was hospitalized after consuming Multani Kaminividravana Rasa due to severe lead poisoning. SA ...

Health authorities in South Australia issued a warning after a person was hospitalised with lead poisoning from the imported ...

The purpose of the survey is to produce estimates of the production of environmental goods and services by industry. This survey collects data on sales of environmental and clean technology goods and ...